Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cardiometrics was a pioneering medical technology company that specialized in the development of intravascular sensors and diagnostic systems for interventional cardiology. The company is best known for inventing the Doppler-tipped guidewire (FlowWire) and the pressure-sensing guidewire (WaveWire), which enabled clinicians to perform physiological assessments of coronary artery disease. These technologies allowed for the measurement of Coronary Flow Reserve (CFR) and laid the groundwork for modern Fractional Flow Reserve (FFR) techniques used to determine the functional significance of arterial blockages. Cardiometrics was acquired by EndoSonics in 1997, and its core technologies eventually became integral components of the physiology portfolios of Volcano Corporation and subsequently Philips.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cardiometrics.